Skip to content

The effects of intraoperative lung protective ventilation strategy on clinical outcomes of patients with traumatic brain injury

The effects of intraoperative lung protective ventilation strategy on clinical outcomes of patients with traumatic brain injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038314
Enrollment
Unknown
Registered
2020-09-17
Start date
2019-12-19
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic brain injury

Interventions

conventional mechanical ventilation group:Tidal volume 10ml/kg corrected body weight, with 0 cmH2O PEEP, and no recruitment maneuvers.
low tidal volume+5cmH2O PEEP group:Tidal volume 8ml/kg corrected body weight, with continuous 5cmH2O PEEP during operation, and no recruitment maneuvers.
low tidal volume+5cmH2O PEEP+recruitment maneuvers group:Tidal volume 8ml/kg corrected body weight, with continuous 5cmH2O PEEP during operation, and recruitment maneuvers were implemented before open

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed with traumatic brain injury and underwent emergency evacuation of hematoma in Subei people's hospital. 2. The patients were of either gender, aged 18-65 years, 3. ASA grade I - II, 4. Body mass index 18.5 ~ 29.9kg/m2.

Exclusion criteria

Exclusion criteria: 1. People with mental or cognitive impairment, or other neurological dysfunction before operation (inflammatory brain diseases, myelitis, epilepsy, dementia, cerebral vascular malformations, etc.); 2. Patients with severe respiratory diseases before operation (lung infection, pneumoconiosis, interstitial lung disease, chronic bronchitis, chronic obstructive pulmonary diseases, asthma, etc.); 3. Patients with severe cardiovascular diseases (rheumatic heart disease, valve heart disease, pericarditis, pulmonary heart disease, myocarditis, etc.); 4. Patients with severe liver and kidney dysfunction (liver cirrhosis, drug-induced liver injury, chronic renal failure, hypertensive nephropathy, etc.); 5. Patients with stroke, cerebral hemorrhage, myocardial infarction, trauma, major surgery, etc. over the past 6 months.

Design outcomes

Primary

MeasureTime frame
PaO2;PaCO2;Cdyn;Ppeak;Pplat;HR;MAP;CPIS;postoperative pulmonary complications;

Secondary

MeasureTime frame
GFAP;UCHL1;ONSD;postoperative neurologic complications;postoperative mechanical ventilation time;GOSE;length of stay;

Countries

China

Contacts

Public ContactJu Gao

Northern Jiangsu People's Hospital

178201049@csu.edu.cn+86 18051063988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026